$3.720
+0.051 (+1.36%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de BCYC por análisis de gráficos similares
Alphio's BCYC stock price prediction model matches the current Bicycle Therapeutics PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.75 (+0.94%). The 1-week path is $3.75 (+0.69%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Bicycle Therapeutics PLC?
Bicycle Therapeutics PLC (BCYC) is currently trading at $3.62, which is significantly below the Oppenheimer price target of $11, suggesting a potential upside of approximately 174%. However, the stock has shown a year-to-date decline of 45.81% and a 52-week range that indicates it is near its low of $3.33. While the gross margin remains strong at 96.8%, the company reported a substantial net loss of $10.48 million in Q3 2026, which is concerning. The RSI of 43.08 indicates the stock is nearing oversold territory, but the overall trend remains bearish. Given these factors, it may be prudent to hold rather than buy at this time, as the risks of further declines are present, especially with a recent earnings miss and declining revenues.
BCYC cerró en $3.72 el Wednesday, tras subir +1.36%
Bicycle Therapeutics PLC (BCYC) last closed at $3.72, gaining +1.36%. These facts feed the 1-day and 1-week BCYC price prediction above.
Factores de la previsión
Los factores de la previsión de Bicycle Therapeutics PLC (BCYC) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de BCYC, ordenadas por similitud.
Análisis de estacionalidad de BCYC
Historically the probability of a positive November return for BCYC is 47.62%. November offers the highest probability of a positive month at 47.62%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de BCYC
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $5.22 | $6.03 | $7.53 | +62.19% |
| Dec 2026 | $6.21 | $7.15 | $7.67 | +92.15% |
En 2026, se proyecta que Bicycle Therapeutics PLC (BCYC) oscile entre $5.22 y $7.67.
Previsión mensual de Bicycle Therapeutics PLC para 2026
En Nov de 2026, se proyecta que Bicycle Therapeutics PLC promedie $6.03, con un mínimo de $5.22 y un máximo de $7.53.
En Dec de 2026, se proyecta que Bicycle Therapeutics PLC promedie $7.15, con un mínimo de $6.21 y un máximo de $7.67.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.